Barriers to fluorescein and protein movement
- PMID: 2413231
Barriers to fluorescein and protein movement
Abstract
Vitreous fluorophotometry assesses the leakage of fluorescein through the primary blood-retinal barrier composed of retinal capillaries and the pigment epithelium. However, other ocular barriers exist that may differentiate between the small molecules of fluorescein and the larger ones of protein. We injected solutions containing carboxyfluorescein and several sizes of fluoresceinated dextran into the subretinal space of rabbit eyes. Carboxyfluorescein diffused rapidly through the retina into the vitreous, but dextrans of a size comparable to proteins crossed the retina very poorly. Large dextrans persisted for days in the subretinal space, although the fluid injected with them disappeared within a few hours. Vitreous fluorophotometry must be interpreted with the knowledge that the retina is much more of a barrier to protein than to fluorescein.
Similar articles
-
The active transport of fluorescein by the retinal vessels and the retina.J Physiol. 1967 Aug;191(3):467-86. doi: 10.1113/jphysiol.1967.sp008262. J Physiol. 1967. PMID: 4963870 Free PMC article.
-
Kinetics of macromolecules injected into the subretinal space.Exp Eye Res. 1985 May;40(5):687-96. doi: 10.1016/0014-4835(85)90138-1. Exp Eye Res. 1985. PMID: 2408910
-
Estimation of the permeability of the blood-retinal barrier in normal individuals.Invest Ophthalmol Vis Sci. 1985 Jul;26(7):969-76. Invest Ophthalmol Vis Sci. 1985. PMID: 4008211
-
Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.Acta Ophthalmol Suppl (1985). 1993;(211):1-52. Acta Ophthalmol Suppl (1985). 1993. PMID: 8318868 Review.
-
[Delivery of macromolecular drugs to the vitreous and its peripheral tissues].Nihon Rinsho. 1998 Mar;56(3):628-31. Nihon Rinsho. 1998. PMID: 9549347 Review. Japanese.
Cited by
-
Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment.Arq Bras Oftalmol. 2022 Feb 14;85(6):606-613. doi: 10.5935/0004-2749.20220088. eCollection 2022. Arq Bras Oftalmol. 2022. PMID: 35170645 Free PMC article.